Sunday, February 04, 2018 10:34:02 AM
OWCP’s primary asset, and the one that we think will drive the most near-term value, is a psoriasis cream. It is a topical compound designed to ensure the effective delivery and dosage of a proprietary cannabinoid-based topical cream, and it is basically in its final round of efficacy testing before it hits the shelves. The company expects to have it commercially available in the US and Israel by the end of the first quarter, with a sales push starting second quarter.
https://insiderfinancial.com/owc-pharmaceutical-research-corp-otcmktsowcp-could-be-the-next-gw-pharmaceuticals-plc-adr-nasdaqgwph/119689/
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM